These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1026 related items for PubMed ID: 12151468

  • 1. Risperidone in children with autism and serious behavioral problems.
    McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D, Research Units on Pediatric Psychopharmacology Autism Network.
    N Engl J Med; 2002 Aug 01; 347(5):314-21. PubMed ID: 12151468
    [Abstract] [Full Text] [Related]

  • 2. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Am J Psychiatry; 2005 Jul 01; 162(7):1361-9. PubMed ID: 15994720
    [Abstract] [Full Text] [Related]

  • 3. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.
    Paediatr Drugs; 2013 Dec 01; 15(6):505-14. PubMed ID: 23821414
    [Abstract] [Full Text] [Related]

  • 4. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov 01; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 5. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.
    J Child Adolesc Psychopharmacol; 2015 Aug 01; 25(6):482-93. PubMed ID: 26262903
    [Abstract] [Full Text] [Related]

  • 6. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL.
    Pediatrics; 2009 Dec 01; 124(6):1533-40. PubMed ID: 19948625
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Scahill L, Minderaa RB, Hoekstra PJ.
    J Am Acad Child Adolesc Psychiatry; 2005 Nov 01; 44(11):1137-44. PubMed ID: 16239862
    [Abstract] [Full Text] [Related]

  • 8. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ, Kodesh A, Goldberg Y, Reichenberg A, Furukawa TA, Kolevzon A, Leucht S.
    Eur Psychiatry; 2016 Feb 01; 32():16-20. PubMed ID: 26802979
    [Abstract] [Full Text] [Related]

  • 9. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
    Ghaleiha A, Ghyasvand M, Mohammadi MR, Farokhnia M, Yadegari N, Tabrizi M, Hajiaghaee R, Yekehtaz H, Akhondzadeh S.
    J Psychopharmacol; 2014 Jul 01; 28(7):677-85. PubMed ID: 24132248
    [Abstract] [Full Text] [Related]

  • 10. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 01; 28(1):74-81. PubMed ID: 29027815
    [Abstract] [Full Text] [Related]

  • 11. Role of risperidone in children with autism spectrum disorder.
    Chavez B, Chavez-Brown M, Rey JA.
    Ann Pharmacother; 2006 May 01; 40(5):909-16. PubMed ID: 16684811
    [Abstract] [Full Text] [Related]

  • 12. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A, Alikhani R, Kazemi MR, Mohammadi MR, Mohammadinejad P, Zeinoddini A, Hamedi M, Shahriari M, Keshavarzi Z, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2016 Nov 01; 26(9):784-791. PubMed ID: 27128958
    [Abstract] [Full Text] [Related]

  • 13. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
    Ghanizadeh A, Moghimi-Sarani E.
    BMC Psychiatry; 2013 Jul 25; 13():196. PubMed ID: 23886027
    [Abstract] [Full Text] [Related]

  • 14. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A, Germanò E, Pustorino G, Impallomeni C, D'Arrigo C, Calamoneri F, Spina E.
    J Child Adolesc Psychopharmacol; 2004 Jul 25; 14(1):39-47. PubMed ID: 15142390
    [Abstract] [Full Text] [Related]

  • 15. Risperidone in children with autism: randomized, placebo-controlled, double-blind study.
    Nagaraj R, Singhi P, Malhi P.
    J Child Neurol; 2006 Jun 25; 21(6):450-5. PubMed ID: 16948927
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249
    [Abstract] [Full Text] [Related]

  • 17. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A, Ayoobzadehshirazi A.
    Pediatr Neurol; 2015 Jan 01; 52(1):77-81. PubMed ID: 25451017
    [Abstract] [Full Text] [Related]

  • 18. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B.
    Am J Psychiatry; 2005 Jun 01; 162(6):1142-8. PubMed ID: 15930063
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.
    Arch Gen Psychiatry; 1998 Jul 01; 55(7):633-41. PubMed ID: 9672054
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S.
    Psychopharmacology (Berl); 2013 Jan 01; 225(1):51-9. PubMed ID: 22782459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.